Rajdeep Gaitonde, DO
Clinical Cardiac Electrophysiology · Louisville, KYNPI 1225087612
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Abbott at 45.8% of the total. Reporting peaked in 2021 at $134,742 and has fallen 83.3% since, to $22,508 in 2025. Among clinical cardiac electrophysiology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 758 payments — averaging $532.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$185K
- Elutia, Inc.$164K
- Medtronic$22K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$20K
- Boston Scientific$7K
- Stereotaxis Inc$1K
- plus $4K from 16 others
Across 3 payments — averaging $3016.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Elutia, Inc.$9K
- Abbott$250
What the payments were for
- Consulting fees$169,52742%
- Speaking & faculty fees$164,45041%
- Travel & lodging$37,8419%
- Food & beverage$31,9298%
- Entertainment$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 437 | $184,831 |
| Elutia, Inc. | 50 | $164,412 |
| Medtronic(2 entities) | 80 | $21,766 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 46 | $20,409 |
| Boston Scientific | 46 | $6,884 |
| Stereotaxis Inc | 7 | $1,487 |
| Acutus Medical, Inc. | 10 | $1,098 |
| Novartis | 29 | $642 |
| Atricure, Inc. | 7 | $635 |
| Cardiva Medical, Inc. | 2 | $262 |
| Impulse Dynamics (USA) Inc. | 2 | $254 |
| Amgen | 15 | $245 |
| Cvrx, Inc. | 1 | $196 |
| W. L. Gore & Associates, Inc. | 1 | $180 |
| Johnson & Johnson | 5 | $165 |
| E.r. Squibb & Sons, L.L.C. | 6 | $114 |
| Pfizer | 5 | $80 |
| Merck | 4 | $76 |
| Scpharmaceuticals Inc. | 2 | $44 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| Altathera Pharmaceuticals LLC | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ECM Patch,Pouch$163,953
- Ensite Cardiac Mapping System$60,386
- Allure CRT Pacemaker$26,600
- Confirm Rx$20,411
- LifeVest$19,333
- Accent Pacemaker$15,353
- Perclose ProStyle$12,497
- Endurity Pacemaker$10,950
- AVEIR$7,924
- Advisor Catheter$6,466
- ENSITE PRECISION$4,719
- EnSite Precision Cardiac Mapping System$4,008
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$3,150
- TYRX$2,166
- CardioMEMS HF System$1,851
- EVERA MRI XT DR SURESCAN$1,554
- Quadra Allure MP RF CRT Pacemkr$983
- Reveal LINQ$937
- Arctic Front$890
- GENERAL - THERAPIES$847
How this compares
$403,834 in reported general payments places this provider in the 95th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
See all clinical cardiac electrophysiology providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 571 | $513,114 |
| EntrestoSacubitril/Valsartan | 81 | $109,112 |
| XareltoRivaroxaban | 94 | $106,483 |
| FarxigaDapagliflozin Propanediol | 34 | $28,646 |
| JardianceEmpagliflozin | 15 | $10,745 |
| BrilintaTicagrelor | 21 | $9,270 |
| Amiodarone Hcl | 396 | $8,806 |
| Metoprolol Succinate | 436 | $6,011 |
| Ranolazine ErRanolazine | 17 | $2,791 |
| Bumetanide | 50 | $2,325 |
| Flecainide Acetate | 48 | $2,089 |
| Digoxin | 92 | $1,790 |
| Atorvastatin Calcium | 225 | $1,519 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 67 | $1,458 |
| Amlodipine Besylate | 252 | $1,223 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $80 | $513,114571 claims |
| NovartisEntresto | $642 | $109,11281 claims |
| Johnson & JohnsonXarelto | $165 | $106,48394 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
Other clinical cardiac electrophysiology in Louisville
- Jeffrey StidamLouisville$196K
- Kent MorrisLouisville$187K
- Kevin ParrottLouisville$60K
- Megan GruberLouisville$46K
- Nachiket ApteLouisville$44K
- Abhishek BoseLouisville$39K
- Michael YuLouisville$32K
- Christopher JohnsrudeLouisville$23K
- Hassan KhanLouisville$22K
- Kevin ThomasLouisville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.